PAM
IGMS

Panagora Asset Management’s IGM Biosciences IGMS Stock Holding History

Panagora Asset Management’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-23,406
Closed -$161K – 1227
2024
Q2 		$161K Buy
23,406
+87
+0.4% +$744 ﹤0.01% 1149
2024
Q1 		$225K Sell
23,319
-6,954
-23% -$80.6K ﹤0.01% 1132
2023
Q4 		$252K Buy
+30,273
New +$176K ﹤0.01% 1130

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Panagora Asset Management's IGMS Position: Q3 2024 in Review

Panagora Asset Management sold out of IGM Biosciences (IGMS) in Q3 2024, closing a stake of 23,406 shares — an estimated $161K sold.

Panagora Asset Management first reported a position in IGMS in Q4 2023 and held it in 3 quarters. The position peaked at $252K in Q4 2023. 72 funds tracked by Wall St. Rank hold IGMS as of Q3 2024.

  • Panagora Asset Management reported no remaining IGM Biosciences position as of Q3 2024 after selling out during the quarter.
  • Panagora Asset Management sold 23,406 IGM Biosciences shares in Q3 2024, an estimated $161K.
  • Panagora Asset Management first reported a position in IGM Biosciences in Q4 2023 and held it in 3 quarters.
  • Panagora Asset Management's IGM Biosciences position peaked at $252K in Q4 2023.
  • 72 funds tracked by Wall St. Rank held IGM Biosciences as of Q3 2024.

Based on Panagora Asset Management's 13F filing for Q3 2024, filed 13 Nov 2024.